Login to Your Account

Jnana lands $50M financing to back discovery platform

By Michael Fitzhugh
Staff Writer

Friday, December 15, 2017

Jnana Therapeutics Inc., a Boston-based startup building a drug discovery platform targeting a family of proteins that serve as cellular "metabolic gates," has raised a $50 million series A financing.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription